Medicine & Life Sciences
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine
25%
Ado-Trastuzumab Emtansine
23%
Afatinib
21%
Area Under Curve
14%
atezolizumab
100%
Biomarkers
29%
Breast Neoplasms
32%
Clinical Trials
40%
Colorectal Neoplasms
19%
Confidence Intervals
15%
Cytochrome P-450 CYP3A
51%
Cytochrome P-450 Enzyme System
27%
dabrafenib
22%
Drug Interactions
42%
Drug Monitoring
12%
Enzymes
24%
ErbB Receptors
15%
Extracellular Vesicles
38%
GDC-0973
29%
Glucuronosyltransferase
51%
Immunotherapy
18%
In Vitro Techniques
12%
Kinetics
12%
Lapatinib
16%
Liquid Biopsy
20%
Liver
32%
Liver Microsomes
21%
Lung
14%
Lung Neoplasms
14%
Melanoma
26%
Meta-Analysis
20%
Midazolam
23%
Modafinil
19%
Monoclonal Antibodies
14%
Mutation
13%
Neoplasms
24%
Non-Small Cell Lung Carcinoma
46%
pazopanib
17%
Pharmaceutical Preparations
57%
Pharmacokinetics
38%
Phosphotransferases
16%
Progression-Free Survival
58%
Proton Pump Inhibitors
20%
Rifampin
15%
Sorafenib
25%
Survival
66%
Therapeutics
23%
trametinib
14%
Vascular Endothelial Growth Factor A
15%
Vemurafenib
34%
Chemical Compounds
(-)-Cotinine
6%
4-Methylumbelliferone
5%
Amitriptyline
6%
Antidepressant Agent
6%
Biological Marker
8%
Blood Pressure
5%
Canagliflozin
8%
Cardiovascular Agent
7%
Clarithromycin
6%
Clint
6%
Clozapine
6%
Css
7%
Cytochrome P450
16%
Dabrafenib
10%
Dapagliflozin
8%
Doxepin
7%
Drug
40%
Fatty Acid
9%
Genetic Polymorphism
7%
Glucuronic Acid
5%
Ibrutinib
9%
Inhibition of Enzyme
6%
Lapatinib
12%
Mianserin
7%
Midazolam
8%
Morphine
10%
Mycophenolic Acid
6%
Neuroleptic Agent
6%
Nintedanib
12%
Olanzapine
6%
Organic Anion
5%
Pazopanib
13%
Pharmacokinetics
15%
Pharmacological Metabolism
19%
Phenacetin
6%
Phosphotransferase Inhibitor
24%
Plasma
5%
Plasma Concentration
7%
Propofol
5%
Protein
5%
Regorafenib
15%
Sorafenib
19%
Steroid Hormone
5%
Sulfinpyrazone
7%
Teriflunomide
8%
Trametinib
11%
Twice Daily
6%
Tyrosine Kinase Inhibitor
6%
Vemurafenib
8%
Xenobiotic Agent
6%